| Sep 5 |
We're Hopeful That Acrivon Therapeutics (NASDAQ:ACRV) Will Use Its Cash Wisely
|
| Aug 15 |
Are Medical Stocks Lagging Acrivon Therapeutics, Inc. (ACRV) This Year?
|
| Aug 13 |
Acrivon Therapeutics GAAP EPS of -$0.52
|
| Aug 13 |
Acrivon Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
|
| Jun 21 |
Is Acrivon Therapeutics, Inc. (ACRV) Stock Outpacing Its Medical Peers This Year?
|
| Jun 13 |
Acrivon Therapeutics: Can You Win In Clinical Trials With Selection Bias?
|
| Jun 5 |
Is Acrivon Therapeutics, Inc. (ACRV) Outperforming Other Medical Stocks This Year?
|
| May 29 |
Acrivon Therapeutics to Present at the Jefferies Global Healthcare Conference
|
| May 28 |
Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock
|
| May 24 |
5 Small Drug Stocks to Buy From a Recovering Industry
|
